| 000 | 01020pam a2200277 a 4500 | ||
|---|---|---|---|
| 005 | 20250914134252.0 | ||
| 008 | 040901s2002 xxua b 001 0 eng b | ||
| 020 |
_a1574911201 (hard) _cRM1,300.25 |
||
| 039 | 9 |
_a200504041656 _blailawati _c200503281202 _dzainol _y09-01-2004 _zfida |
|
| 060 | _aQV778 | ||
| 090 | _aQV778.P532 2004 | ||
| 245 | 0 | 0 |
_aPharmaceutical preformulation and formulation : _ba practical guide from candidate drug selection to commercial dosage form / _cMark Gibson, editor |
| 260 |
_aDenver, Colo. : _bInterpharm Press, _c2002 |
||
| 300 |
_axi, 596 p. : _bill. ; _c26 cm. |
||
| 504 | _aReferences : p. 569-579 | ||
| 650 | 2 |
_aBiopharmaceutics _xmethods |
|
| 650 | 2 |
_aChemistry, Pharmaceutical _xmethods |
|
| 650 | 2 | _aDrug evaluation | |
| 700 | 1 |
_aGibson, Mark, _d1957- |
|
| 907 |
_a.b13425250 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQV778.P532 2004 |
||
| 914 | _avtls003294356 | ||
| 991 | _aJabatan Farmasi | ||
| 998 |
_ad _b2004-01-09 _cm _da _feng _gxxu _y0 _z.b13425250 |
||
| 999 |
_c341802 _d341802 |
||